The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Growth In Market Value Is Anticipated For The One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Between 2026 And 2030?

The market size for the one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics has witnessed exponential expansion in recent years. This market is projected to increase from $1.49 billion in 2025 to $1.79 billion in 2026, driven by a compound annual growth rate (CAGR) of 20.1%. Historically, this growth can be attributed to several factors including the expansion of molecular diagnostics, broader CRISPR research, an uptick in infectious disease testing, heightened demand for rapid tests, and progress in genomics technology.

The one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market size is anticipated to undergo significant expansion in the coming years. The market is forecast to expand, reaching $3.75 billion in 2030 at a compound annual growth rate (CAGR) of 20.4%. This growth in the forecast period can be attributed to the broadening of point-of-care molecular testing, an increasing demand for rapid pathogen detection, the progression of personalized diagnostics, greater clinical adoption of crispr technology, and more widespread field-deployable testing. Key trends expected during this period include rapid crispr-based diagnostic assays, point-of-care crispr testing kits, multiplex gene detection panels, portable molecular crispr platforms, and affordable nucleic acid detection kits.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33249&type=smp

Which Growth Factors Are Strengthening The One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Landscape?

The increasing occurrence of infectious diseases is anticipated to stimulate the expansion of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market in the future. These illnesses stem from harmful microorganisms entering the body and can spread through various means like physical contact, air, water, or vectors. The rise in urbanization and high population density contributes to the increased spread of these diseases, as they facilitate quicker pathogen transmission. HOLMES CRISPR Diagnostics aids in identifying infectious diseases by employing CRISPR-Cas enzymes to precisely and rapidly pinpoint specific genetic sequences belonging to pathogens, thus allowing for quick, sensitive, and on-site diagnosis. For instance, in February 2024, data from GOV.UK, a UK government department, indicated a 10.7% increase in tuberculosis (TB) cases in England in 2023, rising from 4,380 in 2022 to 4,850. Consequently, the growing prevalence of infectious diseases is driving the growth of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market. The increasing uptake of precision medicine is anticipated to drive the expansion of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market going forward. Precision medicine focuses on providing individualized healthcare by taking into account an individual’s genetic makeup, environmental influences, and lifestyle choices. Its adoption is on the rise because of progress in genomics, which allows medical professionals to pinpoint genetic variations and formulate specific treatments, thereby enhancing patient results. The HOLMES CRISPR diagnostics system contributes to precision medicine by swiftly and precisely identifying particular genetic mutations or pathogens within a patient’s DNA or RNA, which facilitates customized treatments and prompt interventions aligned with a person’s unique genetic profile. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 novel personalized treatments for patients with rare diseases, a significant increase from six in 2022. The new personalized treatments approved for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Therefore, the growing application of precision medicine is propelling the growth of the hybrid oligonucleotide-linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market.

How Does Segment Analysis Break Down The One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Structure?

The one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market covered in this report is segmented –

1) By Product Type: Kits; Instruments; Reagents; Other Product Types

2) By Service Type: Sample Collection And Preparation Services; Assay Development And Validation Services; Data Interpretation And Reporting Services; Quality Control And Assurance Services

3) By Application: Infectious Disease Diagnosis; Oncology; Genetic Disease Screening; Other Applications

4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End-Users

Subsegments:

1) By Kits: Single Target Diagnostic Kits; Multiplex Diagnostic Kits; Point Of Care Testing Kits; Laboratory Use Diagnostic Kits; Disease Specific Diagnostic Kits

2) By Instruments: Benchtop Diagnostic Instruments; Portable Diagnostic Devices; Automated Detection Systems; Sample Preparation Instruments; Integrated Analysis Platforms

3) By Reagents: Enzyme Based Reagents; Nucleic Acid Extraction Reagents; Amplification Reaction Reagents; Detection And Reporting Reagents; Sample Stabilization Reagents

4) By Other Product Types: Consumables And Accessories; Quality Control Materials; Calibration Standards; Disposable Testing Components; Supporting Laboratory Supplies

Who Are The Businesses Driving Activity In The One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market?

Major companies operating in the one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, OraSure Technologies Inc., Molbio Diagnostics Pvt. Ltd., New England Biolabs Inc., Horizon Discovery Group plc, Mammoth Biosciences, Synthego Corporation, Binx Health Inc., Sherlock Biosciences Inc., Caspr Biotech, Tolo Biotechnology Co. Ltd., CrisprBits Private Limited, Scope Biosciences.

Access The Complete One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/one-hour-low-cost-multipurpose-highly-efficient-system-holmes-clustered-regularly-interspaced-short-palindromic-repeats-crispr-diagnostics-market-report

Which Regional Market Leads The One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market?

North America was the largest region in the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model